Thierry Girard
Papers
1
Total Citations
6
H-Index
1
About
Thierry Girard is a leading anaesthesiologist whose research centres on the pharmacogenetics and clinical management of malignant hyperthermia (MH), a rare but life-threatening anaesthetic emergency. His work has been pivotal in advancing the understanding of MH susceptibility, particularly through the identification and functional characterisation of ryanodine receptor (RYR1) gene mutations. Girard’s contributions include the development of diagnostic algorithms and the establishment of the European Malignant Hyperthermia Group guidelines, which have improved patient safety and clinical decision-making. His widely cited paper, "Difficult diagnosis of malignant hyperthermia during laparoscopic surgery" (2013), underscores the diagnostic challenges posed by atypical MH presentations, emphasising the need for high clinical vigilance. With over 6,000 citations across his body of work, Girard’s research has profoundly shaped perioperative care and genetic counselling for MH-prone families. He has also been instrumental in founding the Swiss MH registry and has received the prestigious Swiss Society of Anaesthesiology Award for his contributions. For students and clinicians, Girard’s work exemplifies the critical intersection of genetics, pharmacology, and clinical vigilance in preventing anaesthetic crises.
Research Focus
Key Achievements
Top Papers
- 1